Chicago Equity Partners’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-7,590
Closed -$724K 935
2019
Q1
$724K Sell
7,590
-8,065
-52% -$1.01M 0.03% 591
2018
Q4
$1.94M Sell
15,655
-370
-2% -$60.9K 0.08% 344
2018
Q3
$3.91M Buy
16,025
+420
+3% +$97.1K 0.12% 248
2018
Q2
$2.91M Buy
15,605
+700
+5% +$116K 0.09% 315
2018
Q1
$1.83M Sell
14,905
-7,890
-35% -$963K 0.06% 390
2017
Q4
$2.71M Buy
22,795
+6,670
+41% +$734K 0.08% 309
2017
Q3
$1.53M Buy
16,125
+2,370
+17% +$228K 0.05% 424
2017
Q2
$1.31M Buy
13,755
+8,555
+165% +$731K 0.04% 453
2017
Q1
$403K Hold
5,200
0.01% 624
2016
Q4
$349K Buy
+5,200
New +$321K 0.01% 649

Other funds holding INGN

Chicago Equity Partners's INGN Position: Q2 2019 in Review

Chicago Equity Partners sold out of Inogen (INGN) in Q2 2019, closing a stake of 7,590 shares — an estimated $724K sold.

Chicago Equity Partners first reported a position in INGN in Q4 2016 and held it in 10 quarters. The position peaked at $3.91M in Q3 2018. 197 funds tracked by Wall St. Rank hold INGN as of Q2 2019.

  • Chicago Equity Partners reported no remaining Inogen position as of Q2 2019 after selling out during the quarter.
  • Chicago Equity Partners sold 7,590 Inogen shares in Q2 2019, an estimated $724K.
  • Chicago Equity Partners first reported a position in Inogen in Q4 2016 and held it in 10 quarters.
  • Chicago Equity Partners's Inogen position peaked at $3.91M in Q3 2018.
  • 197 funds tracked by Wall St. Rank held Inogen as of Q2 2019.

Based on Chicago Equity Partners's 13F filing for Q2 2019, filed 2 Aug 2019.